SCHEMBL1630253

SCHEMBL1630253

COc1ccc(-c2ccnn2-c2cccc(C(=O)O)c2)c(O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 2/20 0.53
ALDH1A1 P00352 4/20 0.46
NPSR1 Q6W5P4 1/20 0.45
STIM1 Q13586 2/20 0.45
ORAI1 Q96D31 2/20 0.45
KDM5A P29375 2/20 0.44
KDM4C Q9H3R0 2/20 0.44
KDM5B Q9UGL1 2/20 0.44
SRC P12931 1/20 0.43
MRGPRX4 Q96LA9 2/20 0.43
RAB9A P51151 2/20 0.43
TP53 P04637 1/20 0.43
PKM P14618 1/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
KDM4A O75164 1/20 0.42
HPGD P15428 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1630086 0.88 NPSR1 (0.52) ALDH1A1NPSR1RAB9ATP53SMN1; SMN2
SCHEMBL1629728 0.87 MAPT (0.49) ALDH1A1NPSR1KDM5AKDM4CKDM5B
SCHEMBL1630489 0.87 PTGER1 (0.55) PTGER1ALDH1A1KDM5AKDM4CKDM5B
SCHEMBL1630238 0.85 MAPT (0.51) ALDH1A1NPSR1RAB9ANFKB1NFKB2
SCHEMBL1631568 0.85 KDM4E (0.57) PTGER1ALDH1A1NPSR1TP53PKM
SCHEMBL1630200 0.82 ALDH1A1 (0.47) ALDH1A1NPSR1SMN1; SMN2HPGDMAPK1
SCHEMBL12722740 0.82 NPSR1 (0.45) PTGER1ALDH1A1NPSR1RAB9ASMN1; SMN2
SCHEMBL1629669 0.80 MAPT (0.60) ALDH1A1NPSR1HPGDLMNAKDM4E
SCHEMBL1629144 0.80 PIK3CD (0.49) ALDH1A1NPSR1RAB9ASMN1; SMN2HPGD
SCHEMBL1628683 0.80 NPBWR1 (0.50) ALDH1A1NPSR1RAB9ATP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP claimed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US claimed
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed
EP-1776346-A1 1,5-DIPHENYLPYRAZOLES Merck Patent GmbH (DE) 2007-04-25 EP disclosed
WO-2006018082-A1 1,5-DIPHENYLPYRAZOLES MERCK PATENT GMBH (DE) 2006-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P PTGER1 1113/4885ALDH1A1 777/4885NPSR1 2769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.